x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Psychopharmacology and Psychiatry Updates

Psychopharmacology Institute

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

health & fitness medicine

All Episodes

07:58

CBD as a Medication

Psychopharmacology and Psychiatry Updates ·

2022/03/23

Can we use CBD for psychiatric disorders? This episode discusses the evidence for medical uses of CBD for various disorders, such as childhood epilepsy, schizophrenia, social anxiety disorder, opioid use disorder, and cannabis use disorder. Faculty: Diana Martinez, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D. Learn more about our memberships here Earn 0.75 CMEs: Medicinal Cannabis and the Psychiatric Patient: Clinical Harm vs Novel Treatment

en

09:41

SSRIs and Suicidality

Psychopharmacology and Psychiatry Updates ·

2022/03/18

Do SSRIs really increase suicide risk? This episode discusses the controversial literature regarding the effect of antidepressant initiation on suicidal ideation. Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 32 Suicidality and Self-Injury With Selective Serotonin Reuptake Inhibitors in Youth: Occurrence, Predictors, and Timing

en

07:33

Cannabis and Cognition

Psychopharmacology and Psychiatry Updates ·

2022/03/13

Does cannabis use cause cognitive deficits? This episode discusses cannabis use and its long-term effects on cognition in adults and younger people. Faculty: Diana Martinez, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D. Learn more about our memberships here Earn 0.75 CMEs: Medicinal Cannabis and the Psychiatric Patient: Clinical Harm vs Novel Treatment Cannabis and Cognition

en

09:46

Clozapine-Induced Myocarditis

Psychopharmacology and Psychiatry Updates ·

2022/03/08

When should you suspect clozapine-induced myocarditis? Myocarditis has nonspecific manifestations. In this episode, Dr. Phelps explains the clinical presentation and the steps to take if you suspect myocarditis. Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 32 Clozapine-Induced Myocarditis: Electronic Health Register Analysis of Incidence, Timing, Clinical Markers, and Diagnostic Accuracy

en

09:35

Does Cannabis Use Cause Psychiatric Disorders?

Psychopharmacology and Psychiatry Updates ·

2022/03/03

This episode discusses cannabis use in patients with a psychiatric disorder. It also addresses the risk of psychosis in people who use cannabis and the relationship to schizophrenia. Faculty: Diana Martinez, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D. Learn more about our memberships here Earn 0.75 CMEs: Medicinal Cannabis and the Psychiatric Patient: Clinical Harm vs Novel Treatment Does Cannabis Use Cause Psychiatric Disorders?

en

19:30

Treatment Strategies for Treatment-Resistant OCD

Psychopharmacology and Psychiatry Updates ·

2022/02/26

When a patient does not respond to an SSRI trial, what is the best strategy—increase the dose, augment with another agent, or switch to another SSRI? In this interview, Dr. Hudak discusses dosing strategies and the treatment of patients with OCD and comorbid psychiatric conditions. Guest: Robert Hudak, M.D. Interviewer: Mohan Gautam, D.O. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about our memberships here Earn 0.5 CMEs: Treatment-Resistant Obsessive-Compulsive Disorder -

en

08:56

Lithium Augmentation for Psychotic Depression

Psychopharmacology and Psychiatry Updates ·

2022/02/21

This episode discusses lithium augmentation for psychotic depression, including evidence from different case series and open-label studies. It also addresses some clinical strategies for lithium augmentation. Faculty: David Osser, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D. Learn more about our memberships here Earn 1.25 CMEs: The Psychopharmacology Algorithm for Psychotic Depression Node 5: Lithium Augmentation

en

10:18

Prevention and Treatment Strategies for Agitation and...

Psychopharmacology and Psychiatry Updates ·

2022/02/16

Which medications can be used for acute and chronic agitation in dementia? For acute agitation, you might consider the use of haloperidol. For chronic agitation, you could consider citalopram: Its efficacy has been found to be equal to that of antipsychotics in randomized trials. Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 31 Agitation and Dementia: Prevention and Treatment Strategies in Acute and

en

12:33

Choosing an Antipsychotic for Psychotic Depression

Psychopharmacology and Psychiatry Updates ·

2022/02/11

This episode discusses how to choose an antipsychotic for psychotic depression combination therapy. It also reviews the efficacy and side effects of first- and second-generation antipsychotics and the evidence of SGAs for psychotic depression. Faculty: David Osser, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D. Learn more about our memberships here Earn 1.25 CMEs: The Psychopharmacology Algorithm for Psychotic Depression Node 2: Choosing an Antipsychotic for Psychotic Depression

en

08:32

Neurological and Psychiatric Sequelae Due to COVID-19

Psychopharmacology and Psychiatry Updates ·

2022/02/06

COVID-19 infection is associated with new-onset neurological illness but at relatively low absolute rates. On the other hand, rates for new-onset anxiety and mood disorders can be higher, at 7% and 8%, respectively. Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 31 Six-Month Neurological and Psychiatric Outcomes in 236,379 Survivors of COVID-19: A Retrospective Cohort Study Using Electronic Health

en

10:40

SNRIs + Antipsychotics for Psychotic Depression

Psychopharmacology and Psychiatry Updates ·

2022/02/01

Which is the best antidepressant for combination treatment in psychotic depression? This episode includes the use of venlafaxine plus quetiapine and how to choose an antidepressant for combination treatment. Faculty: David Osser, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D. Learn more about our memberships here Earn 1.25 CMEs: The Psychopharmacology Algorithm for Psychotic Depression Node 2C: Combination Therapy: SNRIs + Antipsychotics

en

18:42

Approaches for Addressing Tobacco Use Disorder

Psychopharmacology and Psychiatry Updates ·

2022/01/27

How can we counsel patients about smoking cessation? In this interview, Dr. Joji Suzuki emphasizes the advantages of motivational interviewing and discusses some pharmacologic treatments, such as nicotine replacement therapies, varenicline, and bupropion. Guest: Joji Suzuki, M.D. Interviewer: Wegdan Rashad, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about our memberships here Earn 0.5 CMEs: The Clinical Guide On Tobacco Use Disorder - Interview with Joji Suzuki, M.D.

en

10:01

ECT the First-Choice Treatment for Psychotic Depression

Psychopharmacology and Psychiatry Updates ·

2022/01/22

This episode discusses the use of ECT for severely ill patients, including its benefits and limitations, as well as the use of ECT as a maintenance treatment. Faculty: David Osser, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D. Learn more about our memberships here Earn 1.25 CMEs: The Psychopharmacology Algorithm for Psychotic Depression Node 1: ECT for Severely Ill Patients

en

10:09

Metabolic Characteristics of Newer Second-Generation...

Psychopharmacology and Psychiatry Updates ·

2022/01/17

What was the difference among antipsychotics? Over 1 year, lurasidone caused no net weight gain, whereas olanzapine caused a gain of 10 pounds. Perphenazine was associated with a 2 lb. loss vs olanzapine's 9.5 lb. gain. Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 30 Comparison of the Metabolic Characteristics of Newer Second-Generation Antipsychotics

en

09:16

Prescribing Antipsychotics During Breastfeeding

Psychopharmacology and Psychiatry Updates ·

2022/01/12

This episode discusses first- and second-generation antipsychotics during breastfeeding, including clozapine, the only psychiatric drug nearly always contraindicated. Faculty: Lauren Osborne, M.D. Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D. Learn more about our memberships here Earn 1 CME: Understanding the Use of Psychotropic Drugs in Lactation Antipsychotics During Breastfeeding

en

09:40

Fluvoxamine for Treating COVID-19

Psychopharmacology and Psychiatry Updates ·

2022/01/07

How effective is fluvoxamine in patients with COVID-19? A 2-week course of full-dose fluvoxamine decreased clinical deterioration in outpatients with symptomatic COVID-19 infection. Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Lorena Rodríguez, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 30 Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19

en

12:07

Prescribing Antidepressants During Breastfeeding

Psychopharmacology and Psychiatry Updates ·

2022/01/02

Can we use antidepressants during breastfeeding? This episode discusses the use of antidepressants during breastfeeding, including SSRIs, TCAs, bupropion, and mirtazapine. Faculty: Lauren Osborne, M.D. Hosts: Jessica Diaz, M.D.; Lorena Rodríguez M.D. Learn more about our memberships here Earn 1 CME: Understanding the Use of Psychotropic Drugs in Lactation Antidepressants During Breastfeeding

en

18:22

Treatment Strategies for Acute and Chronic Insomnia

Psychopharmacology and Psychiatry Updates ·

2021/12/28

Is it safe to use atypical antipsychotics for insomnia? Can we use benzodiazepines? This podcast features the different treatments for acute and chronic insomnia. It also addresses the differential diagnoses and some treatment options for insomnia and comorbid depressive disorders. Guest: Charles Reynolds M.D. Interviewer: Mohan Gautam D.O. Hosts: Jessica Diaz, M.D.; Lorena Rodríguez, M.D. Learn more about our memberships here Earn 0.5 CMEs: The Clinical Guide to Sleep Issues in Psychiatry -

en

07:56

Drug Use in Breastfeeding and Adverse Effects

Psychopharmacology and Psychiatry Updates ·

2021/12/23

When it comes to drug use while breastfeeding, what really matters is not the infant dose but the effect on the infant. This episode discusses drug use in breastfeeding, common adverse reactions, and their relationship to maternal dosing. Faculty: Lauren Osborne, M.D. Hosts: Jessica Diaz, M.D.; Lorena Rodríguez M.D. Learn more about our memberships here Earn 1 CME: Understanding the Use of Psychotropic Drugs in Lactation Drug Use in Breastfeeding and Adverse Effects

en

11:37

Marine Omega-3 Fatty Acid Supplementation for BPD

Psychopharmacology and Psychiatry Updates ·

2021/12/18

A novel medication approach for borderline personality disorder is discussed. In this meta-analysis of fish oil for borderline personality disorder, the effect size relative to placebo was 0.54 (substantial) and for affective dysregulation was 0.74 (clinically very relevant). Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Lorena Rodríguez, M.D. Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 29 Marine Omega-3 Fatty Acid Supplementation for Borderline Personality

en

427 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown